Literature DB >> 2371972

The gastric juice urea and ammonia levels in patients with Campylobacter pylori.

H Kim1, C Park, W I Jang, K H Lee, S O Kwon, S S Robey-Cafferty, J Y Ro, Y B Lee.   

Abstract

The authors studied gastric juice ammonia and urea nitrogen levels to determine how they are altered by gastric Campylobacter pylori (CP) infection. Patients with chronic gastritis (20), peptic ulcer (24), hepatic cirrhosis (10), chronic renal failure (13), or gastric remnant (20) were included. Endoscopic biopsy specimens stained with the Warthin-Starry stain were evaluated for the presence of CP. Blood and gastric juice analysis was performed for 11 of the patients with chronic renal failure and 37 patients from the remaining groups. CP was identified in gastric biopsies from 50 of 87 (57.5%) patients, including 87.5% with peptic ulcer and 40-50% of those with chronic gastritis, cirrhosis, chronic renal failure, or gastric remnant. CP infection had no effect on blood urea nitrogen or blood ammonia levels in any group of patients. The urea nitrogen level of gastric juice was higher in patients with chronic renal failure than in other groups but was not related to CP infection. CP infection was associated with a significant increase in gastric juice ammonia levels, both in patients with chronic renal failure (23.3 mmol/L vs. 2.90 mmol/L; [P less than 0.05]) and in other groups (5.48 mmol/L vs. 1.26 mmol/L [P less than 0.0001]). The authors conclude that elevation of gastric juice ammonia level is an indicator of gastric CP infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2371972     DOI: 10.1093/ajcp/94.2.187

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Measurement of urea and ammonium concentrations in gastric juice.

Authors:  W D Neithercut; A M el Nujumi; K E McColl
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

2.  Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability.

Authors:  Nora J Foegeding; Krishnan Raghunathan; Anne M Campbell; Sun Wook Kim; Ken S Lau; Anne K Kenworthy; Timothy L Cover; Melanie D Ohi
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

3.  Bile acid reflux and possible inhibition of Helicobacter pylori infection in subjects without gastric surgery.

Authors:  Y Kawai; S Tazuma; M Inoue
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

4.  Helicobacter pylori arginase mutant colonizes arginase II knockout mice.

Authors:  Songhee H Kim; Melanie L Langford; Jean-Luc Boucher; Traci L Testerman; David J McGee
Journal:  World J Gastroenterol       Date:  2011-07-28       Impact factor: 5.742

5.  Breath ammonia measurement in Helicobacter pylori infection.

Authors:  David J Kearney; Todd Hubbard; David Putnam
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

6.  Peptic ulcer surgery in patients with liver cirrhosis.

Authors:  T Lehnert; C Herfarth
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

7.  Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure.

Authors:  W D Neithercut; P A Rowe; A M el Nujumi; S Dahill; K E McColl
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

8.  Gastric and pancreatic functions in haemodialyzed patients.

Authors:  J Malyszko; S Sosnowski; M Mazerska; M Raimer; J Romatowski; J Stasiewicz; A Kemona; M Mysliwiec
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

9.  Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function.

Authors:  D Jaspersen; W Fassbinder; P Heinkele; H Kronsbein; W Schorr; C Raschka; M Brennenstuhl
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

10.  Helicobacter pylori requires an acidic environment to survive in the presence of urea.

Authors:  M Clyne; A Labigne; B Drumm
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.